Apogee Therapeutics CFO Jane Henderson Gifts 15,000 Shares

What Happened Jane Henderson, Chief Financial Officer of Apogee Therapeutics (APGE), reported a gift of 15,000 shares on July 24, 2026. The Form 4 lists the transaction as a disposition (code G) with an acquisition/disposition price of $0.00 and total reported value of $0. This was a bona fide gift of securities to a donor-advised fund (per filing footnote).

Key Details

• Transaction date: 2026-07-24
• Transaction type/code: Gift (G) — 15,000 shares disposed
• Reported price: $0.00; reported total value: $0
• Footnote: F1 — gift of securities to a donor-advised fund
• Shares owned after transaction: not specified in the provided filing summary
• Timeliness: Period of report and filing date are both 2026-07-24 (filed timely)

Context Gifts of stock (to donor-advised funds or charities) are typically charitable or tax-planning actions and should not be interpreted as a direct signal of the insider’s view on the company’s near-term stock prospects. This report documents the transfer of shares, not a market sale.